Unit of Clinical Investigation,Centre Hospitalo-Universitaire de Rennes
Rennes, 35033 Rennes Cedex 9, France
NCT Number: NCT02031497
The purpose of this study is to determine whether consumption of carbonated drinks containing sweeteners affect insulin sensitivity.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Rennes, 35033 Rennes Cedex 9, France
Sweeteners are natural or synthetic sugar substitutes which provide a sweetness taste to drink and food with few or no additional calories. Sweeteners are widely used in commercialized beverages. Despite some debate, no significant toxicity was demonstrated at a reasonable level of consumption (less than 20 cans per day). However little data is available on the metabolic effects of a regular consumption of beverages containing sweeteners. The objective of the study is to evaluate the effect of a regular consumption (twice a day for 12 weeks) of a carbonated drink with sweeteners, in a normal diet, compared with unsweetened sparkling water on insulin sensitivity in healthy normoweight and overweight subjects.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will have to consume a 330ml can of a drink with sweeteners twice per day as part of their usual fluid intake for 12 weeks.
Subjects will have to consume a 330ml can of a drink without sweeteners twice per day as part of their usual fluid intake for 12 weeks.
Time frame: Before and after each of the two 12-week intervention period
Time frame: Before and after each of the two 12-week intervention period
Time frame: Before and after each of the two 12-week intervention period
Time frame: Before and after each of the two 12-week intervention period
Time frame: Before and after each of the two 12-week intervention period
Time frame: Before and after each of the two 12-week intervention period
Institute For European Expertise in Physiology
Industry
Acronym: SEDULC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07194772
Glucose Homeostasis, Glucose Intolerance
Ottawa, Ontario, Canada
View Trial DetailsNCT00822003
Glucose Homeostasis, Glucose Metabolism Disorders
Basel, Canton of Basel-City, Switzerland
View Trial DetailsNCT07169591
Glucose Homeostasis, Glucose Metabolism Disorders
Hamilton, Ontario, Canada
View Trial DetailsNCT06686888
Glucose Homeostasis, Intestinal Absorption
Leuven, Belgium
View Trial Details